Literature DB >> 19467834

Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.

A Prabhu1, D I Sujatha, N Kanagarajan, M A Vijayalakshmi, Benjamin Ninan.   

Abstract

Ischemic reperfusion injury due to oxidative stress remains one of the challenging problems during cardiac surgeries. The imbalance in the production of free radicals and antioxidants in vivo determines the extent of oxidative stress. The use of antioxidants in cardioplegia has become an important strategy to salvage the myocardium from the attack of these radicals. The objective of this study was to analyze the cardioprotective effect of N-acetylcysteine (NAC) on early reperfusion injury in patients undergoing coronary artery bypass grafting using biochemical markers. Fifty-three patients with left ventricular ejection fraction >0.4 scheduled for coronary artery bypass grafting with cardiopulmonary bypass were selected and divided into two groups. The first group of patients (n=25) received isothermic cardioplegia alone, whereas the second group of patients (n=28) received cardioplegia enriched with NAC (50mg/kg body weight). The free radicals, antioxidants, cardiac troponin I, and hemodynamic and clinical properties of the patients were preoperatively and postoperatively evaluated at five different time intervals. Malondialdehyde level as a measure of free radicals was significantly lower in the NAC-enriched group during reperfusion (p<0.05) and after 12 hr (p<0.05) and 24hr (p<0.001) of surgery. All the antioxidants were elevated in the test group during the reperfusion period (p<0.01). A significant improvement (p=0.001) in the postoperative ejection fraction was noted in the test group. No significant differences were observed between the groups in the level of cardiac troponin I (p=not significant). The use of NAC in patients undergoing coronary artery bypass grafting using cardiopulmonary bypass decreased oxidative stress substantially. However, it did not lead to improvement in the level of cardiac troponin I, a marker of myocardial injury, in our study. Hence, the cardioprotective effect of NAC and the adaptation of the myocardium to oxidative stress should be extensively studied.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19467834     DOI: 10.1016/j.avsg.2008.12.005

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  8 in total

1.  N-Acetyl-L-Cysteine Reduces Fibrosis and Improves Muscle Function After Acute Compartment Syndrome Injury.

Authors:  Benyam Yosef; Yu Zhou; Kathryn Mouschouris; James Poteracki; Shay Soker; Tracy Criswell
Journal:  Mil Med       Date:  2020-01-07       Impact factor: 1.437

Review 2.  Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.

Authors:  Yan-Jun Xu; Paramjit S Tappia; Nirankar S Neki; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

3.  Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery.

Authors:  Wen-fang Xia; Yu Liu; Qing-shan Zhou; Qi-zhu Tang; Han-dong Zou
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

4.  Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.

Authors:  Lisa D Coles; Paul J Tuite; Gülin Öz; Usha R Mishra; Reena V Kartha; Kathleen M Sullivan; James C Cloyd; Melissa Terpstra
Journal:  J Clin Pharmacol       Date:  2017-09-22       Impact factor: 3.126

5.  Efficacy of N-acetylcysteine in Preventing Acute Kidney Injury and Major Adverse Cardiac Events After Cardiac Surgery: A Meta-Analysis and Trial Sequential Analysis.

Authors:  Jingtao Zhao; Maowei Li; Chen Tan
Journal:  Front Med (Lausanne)       Date:  2022-06-22

Review 6.  Cardiopulmonary bypass and oxidative stress.

Authors:  Mustafa Zakkar; Gustavo Guida; M-Saadeh Suleiman; Gianni D Angelini
Journal:  Oxid Med Cell Longev       Date:  2015-02-04       Impact factor: 6.543

7.  N-acetylcysteine use among patients undergoing cardiac surgery: A systematic review and meta-analysis of randomized trials.

Authors:  José Eduardo G Pereira; Regina El Dib; Leandro G Braz; Janaina Escudero; Jason Hayes; Bradley C Johnston
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

8.  Efficacy of N-acetyl cysteine in traumatic brain injury.

Authors:  Katharine Eakin; Renana Baratz-Goldstein; Chiam G Pick; Ofra Zindel; Carey D Balaban; Michael E Hoffer; Megan Lockwood; Jonathan Miller; Barry J Hoffer
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.